News

Bruised investors focus on biotechs with drugs closer to market

Reuters · Leroy Leo · last updated

June 27 (Reuters) — Biotech investors nursing losses from stock price falls are now focusing on firms which are closer to getting their drugs to market, rather than those at the early stages of development.

View full article

Related Knowledge Center: Biotechnology: overview

State of Play

Roundup of developments in biotechnology industries and policymaking. 

More information

here today, more tomorrow

We’ve launched briefing.center with a focus on the press and media.

And we’ve added Citizen Cartwright, a daily quick-read news summary by veteran Washington journalist Linda Cartwright. We’ve also created a new voting rights knowledge center for Citizen Cartwright subscribers. (You can sign up for a dedicated morning email at citizencartwright.com.)

You can sign up here for full access to press and media and Citizen Cartwright on briefing.center.

You can use briefing.center as the center of your information management, or just one of your tools. We’re happy to discuss your information needs.

Sign up